Bariatric intervention improves metabolic dysfunctionassociated steatohepatitis in patients with obesity: A systematic review and meta-analysis
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: Bariatric intervention has been reported to be an effective way to improve metabolic dysfunction- associated steatotic liver disease (MASLD) in obese individuals. The current systemic review aimed to assess the changes in MRI-determined hepatic proton density fat fraction (MRI-PDFF) and nonalcoholic fatty liver disease activity score (NAS) after bariatric surgery or intragastric balloon/gastric banding in MASLD patients with obesity. Methods: We searched various databases including PubMed, OVID Medline, EMBASE, and Cochrane Library. Primary outcomes were the changes in intrahepatic fat on MRI-PDFF and histologic features of metabolic dysfunction- associated steatohepatitis (MASH). Results: Thirty studies with a total of 3,134 patients were selected for meta-analysis. Bariatric intervention significantly reduced BMI (ratio of means, 0.79) and showed 72% reduction of intrahepatic fat on MRI-PDFF at 6 months after bariatric intervention (ratio of means, 0.28). Eight studies revealed that NAS was reduced by 60% at 3–6 months compared to baseline, 40% at 12–24 months, and 50% at 36–60 months. Nineteen studies revealed that the proportion of patients with steatosis decreased by 44% at 3–6 months, 37% at 12–24 months, and 29% at 36–60 months; lobular inflammation by 36% at 12–24 months and 51% at 36–60 months; ballooning degeneration by 38% at 12–24 months; significant fibrosis (≥F2) by 18% at 12–24 months and by 17% at 36–60 months after intervention. Conclusions: Bariatric intervention significantly improved MRI-PDFF and histologic features of MASH in patients with obesity. Bariatric intervention might be the effective alternative treatment option for patients with MASLD who do not respond to lifestyle modification or medical treatment.
Abstract
Background/Aims: Bariatric intervention has been reported to be an effective way to improve metabolic dysfunction- associated steatotic liver disease (MASLD) in obese individuals. The current systemic review aimed to assess the changes in MRI-determined hepatic proton density fat fraction (MRI-PDFF) and nonalcoholic fatty liver disease activity score (NAS) after bariatric surgery or intragastric balloon/gastric banding in MASLD patients with obesity. Methods: We searched various databases including PubMed, OVID Medline, EMBASE, and Cochrane Library. Primary outcomes were the changes in intrahepatic fat on MRI-PDFF and histologic features of metabolic dysfunction- associated steatohepatitis (MASH). Results: Thirty studies with a total of 3,134 patients were selected for meta-analysis. Bariatric intervention significantly reduced BMI (ratio of means, 0.79) and showed 72% reduction of intrahepatic fat on MRI-PDFF at 6 months after bariatric intervention (ratio of means, 0.28). Eight studies revealed that NAS was reduced by 60% at 3–6 months compared to baseline, 40% at 12–24 months, and 50% at 36–60 months. Nineteen studies revealed that the proportion of patients with steatosis decreased by 44% at 3–6 months, 37% at 12–24 months, and 29% at 36–60 months; lobular inflammation by 36% at 12–24 months and 51% at 36–60 months; ballooning degeneration by 38% at 12–24 months; significant fibrosis (≥F2) by 18% at 12–24 months and by 17% at 36–60 months after intervention. Conclusions: Bariatric intervention significantly improved MRI-PDFF and histologic features of MASH in patients with obesity. Bariatric intervention might be the effective alternative treatment option for patients with MASLD who do not respond to lifestyle modification or medical treatment.
참고문헌 (49)
- Khan RS, "Modulation of insulin resistance in nonalcoholic fatty liver disease", Hepatology, 70, pp.711~724 (2019)
- Lee KC, "Pathogenesis and treatment of nonalcoholic steatohepatitis and its fibrosis", Clin Mol Hepatol, 29, pp.77~98 (2023)
- Song SJ, "Implications of comorbidities in nonalcoholic fatty liver disease", Clin Mol Hepatol, 29, pp.384~389 (2023)
- Younossi ZM, "The global epidemiology of NAFLD and NASH in patients with type 2 diabetes : A systematic review and metaanalysis", J Hepatol, 71, pp.793~801 (2019)
- European Association for the Study of the Liver(EASL), "EASL-EASDEASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease", J Hepatol, 64, pp.1388~1402 (2016)
- Park MJ, "Comparison of glucagon-like peptide-1 receptor agonists and thiazolidinediones on treating nonalcoholic fatty liver disease : A network meta-analysis", Clin Mol Hepatol, 29, pp.693~704 (2023)
- Eisenberg D, "2022 American Society for Metabolic and Bariatric Surgery(ASMBS)and International Federation for the Surgery of Obesity and Metabolic Disorders(IFSO) : Indications for Metabolic and Bariatric Surgery", Surg Obes Relat Dis, 18, pp.1345~1356 (2022)
- Zhou H, "Bariatric surgery improves nonalcoholic fatty liver disease : Systematic review and meta-analysis", Obes Surg, 32, pp.1872~1883 (2022)
- Fakhry TK, "Bariatric surgery improves nonalcoholic fatty liver disease : a contemporary systematic review and metaanalysis", Surg Obes Relat Dis, 15, pp.502~511 (2019)
- Lee Y, "Complete resolution of nonalcoholic fatty liver disease after bariatric surgery : A systematic review and meta-analysis", Clin Gastroenterol Hepatol, 17, pp.1040~1060 (2019)
- Mummadi RR, "Effect of bariatric surgery on nonalcoholic fatty liver disease : systematic review and meta-analysis", Clin Gastroenterol Hepatol, 6, pp.1396~1402 (2008)
- Bower G, "Bariatric surgery and non-alcoholic fatty liver disease : A systematic review of liver biochemistry and histology", Obes Surg, 25, pp.2280~2289 (2015)
- Kral JG, "Effects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosis", Surgery, 135, pp.48~58 (2004)
- Taitano AA, "Bariatric surgery improves histological features of nonalcoholic fatty liver disease and liver fibrosis", J Gastrointest Surg, 19, pp.429~436 (2015)
- Gu J, "Diagnostic value of MRI-PDFF for hepatic steatosis in patients with non-alcoholic fatty liver disease : a meta-analysis", Eur Radiol, 29, pp.3564~3573 (2019)
- Nam H, "Effect of exercise-based interventions in nonalcoholic fatty liver disease : A systematic review with meta-analysis", Dig Liver Dis, 55, pp.1178~1186 (2023)
- Han S, "Accuracy of noninvasive scoring systems in assessing liver fibrosis in patients with nonalcoholic fatty liver disease : A systematic review and meta-analysis", Gut Liver, 16, pp.952~963 (2022)
- McInnes MDF, "Preferred reporting items for a systematic review and meta-analysis of diagnostic test accuracy studies : The PRISMA-DTA Statement", JAMA, 319, pp.388~396 (2018)
- Kleiner DE, "Design and validation of a histological scoring system for nonalcoholic fatty liver disease", Hepatology, 41, pp.1313~1321 (2005)
- Lee YM, "Intragastric balloon significantly improves nonalcoholic fatty liver disease activity score in obese patients with nonalcoholic steatohepatitis : a pilot study", Gastrointest Endosc, 76, pp.756~760 (2012)
- von Schönfels W, "Histologic improvement of NAFLD in patients with obesity after bariatric surgery based on standardized NAS(NAFLD activity score)", Surg Obes Relat Dis, 14, pp.1607~1616 (2018)
- Watt MJ, "The liver as an endocrine organ-linking NAFLD and insulin resistance", Endocr Rev, 40, pp.1367~1393 (2019)
- Verna EC, "Role of fatty acids in the pathogenesis of obesity and fatty liver : impact of bariatric surgery", Semin Liver Dis, 28, pp.407~426 (2008)
- Aldoheyan T, "The effects of bariatric surgeries on nonalcoholic fatty liver disease", Surg Endosc, 31, pp.1142~1147 (2017)
- Barker KB, "Non-alcoholic steatohepatitis : effect of Roux-en-Y gastric bypass surgery", Am J Gastroenterol, 101, pp.368~373 (2006)
- Caiazzo R, "Roux-en-Y gastric bypass versus adjustable gastric banding to reduce nonalcoholic fatty liver disease : a 5-year controlled longitudinal study", Ann Surg, 260, pp.893~898 (2014)
- Chaim FDM, "Histological grading evaluation of non-alcoholic fatty liver disease after bariatric surgery : a retrospective and longitudinal observational cohort study", Sci Rep, 10, pp.8496~ (2020)
- Esquivel CM, "Laparoscopic sleeve gastrectomy resolves NAFLD : Another formal indication for bariatric surgery?", Obes Surg, 28, pp.4022~4033 (2018)
- Fazel I, "Modified jejunoileal bypass surgery with biliary diversion for morbid obesity and changes in liver histology during follow-up", J Gastrointest Surg, 11, pp.1033~1038 (2007)
- Furuya CK Jr, "Effects of bariatric surgery on nonalcoholic fatty liver disease : preliminary findings after 2 years", J Gastroenterol Hepatol, 22, pp.510~514 (2007)
- Jaskiewicz K, "Nonalcoholic fatty liver disease treated by gastroplasty", Dig Dis Sci, 51, pp.21~26 (2006)
- Lassailly G, "Bariatric surgery provides long-term resolution of nonalcoholic steatohepatitis and regression of fibrosis", Gastroenterology, 159, pp.1290~1301 (2020)
- Liu X, "Resolution of nonalcoholic steatohepatits after gastric bypass surgery", Obes Surg, 17, pp.486~492 (2007)
- Mathurin P, "Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease", Gastroenterology, 137, pp.532~540 (2009)
- Mattar SG, "Surgically-induced weight loss significantly improves nonalcoholic fatty liver disease and the metabolic syndrome", Ann Surg, 242, pp.610~617 (2005)
- Meinhardt NG, "Hepatic outcomes after jejunoileal bypass : is there a publication bias?", Obes Surg, 16, pp.1171~1178 (2006)
- Moretto M, "Effect of bariatric surgery on liver fibrosis", Obes Surg, 22, pp.1044~1049 (2012)
- Mottin CC, "Histological behavior of hepatic steatosis in morbidly obese patients after weight loss induced by bariatric surgery", Obes Surg, 15, pp.788~793 (2005)
- Parker BM, "Reversal of fibrosis in patients with nonalcoholic steatohepatosis after gastric bypass surgery", BMC Obes, 4, pp.32~ (2017)
- Russo MF, "Insulin resistance is central to long-term reversal of histologic nonalcoholic steatohepatitis after metabolic surgery", J Clin Endocrinol Metab, 106, pp.750~761 (2021)
- Salman MA, "Laparoscopic sleeve gastrectomy on the horizon as a promising treatment modality for NAFLD", Obes Surg, 30, pp.87~95 (2020)
- Salman MA, "Long-term effects of one-anastomosis gastric bypass on liver histopathology in NAFLD cases : a prospective study", Surg Endosc, 35, pp.1889~1894 (2021)
- Verrastro O, "Bariatric-metabolic surgery versus lifestyle intervention plus best medical care in non-alcoholic steatohepatitis(BRAVES) : a multicentre, open-label, randomised trial", Lancet, 401, pp.1786~1797 (2023)
- Folini L, "Liver steatosis(LS)evaluated through chemical-shift magnetic resonance imaging liver enzymes in morbid obesity;effect of weight loss obtained with intragastric balloon gastric banding", Acta Diabetol, 51, pp.361~368 (2014)
- Hedderich DM, "Effects of bariatric surgery on non-alcoholic fatty liver disease : Magnetic resonance imaging is an effective, non-invasive method to evaluate changes in the liver fat fraction", Obes Surg, 27, pp.1755~1762 (2017)
- Luo RB, "How bariatric surgery affects liver volume and fat density in NAFLD patients", Surg Endosc, 32, pp.1675~1682 (2018)
- Mamidipalli A, "Prospective comparison of longitudinal change in hepatic proton density fat fraction(PDFF)estimated by magnitude-based MRI(MRI-M)and complex-based MRI(MRI-C)", Eur Radiol, 30, pp.5120~5129 (2020)
- Pooler BD, "Monitoring fatty liver disease with MRI following bariatric surgery : A prospective, dual-center study", Radiology, 290, pp.682~690 (2019)
- Tan HC, "Multiparametric magnetic resonance imaging and magnetic resonance elastography to evaluate the early effects of bariatric surgery on nonalcoholic fatty liver disease", Int J Biomed Imaging, 2023, pp.4228321~ (2023)